GH Research PLC IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| GH Research PLC | GHRS - NASDAQ |
$14.00-$16.00 | $16.00 | $22.00 | 10 million | 6/25/2021 |
| Cowen, Stifel | ||||||
Co-Manager(s): Canaccord Genuity, JMP Securities | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-06-04 Terms Added 2021-06-21 | ||||||
GH Research PLC Quote & Chart - Click for current quote - GHRS
IPO Boutique aggregates information on public companies and private companies, such as "GHRS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About GH Research PLC (adapted from GH Research PLC prospectus):
They are a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "GHRS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.